Current Staging For Prostate Cancer

Primary Tumor (T) TX Primary tumor cannot be assessed T0 No evidence of primary tumor T1 Clinically unapparent tumor that is not palpable nor visible by imaging T1a Tumor incidental histologic finding in 5% or less of tissue resected by TURP. T1b Tumor incidental histologic finding in more than 5% of tissue resected by TURP. [...]

An Interview with Dr. Kevin Kelly

Today's Medscape had a very interesting and informative interview with Dr. Kevin Kelly. I recommend that you follow the link by clicking the title below and read the interview. Improving Treatment for Advanced Prostate Cancer: An Expert Interview With Dr. Kevin Kelly I would like to thank Frank Kennedy who called my attention to this [...]

BRCA2 Gene Mutation tied to Prostae Cancer Progression and Aggressivness

A recent study in Iceland compared survival and disease progression in prostate cancer patients with the Icelandic BRCA2 999del5 founder mutation and those without the mutation. The study evaluated a pool of men with prostate cancer who were related to women who had breast cancer. They found that the gene mutation, BRCA2 999del5 founder mutation, [...]

Biochemical Failure, PSADT and Morbidity Rates

Those of us who have had a radical prostatectomy and then have our PSA return are experiencing what the industry calls a biochemical recurrence. As with all things prostate cancer, there is a lack of agreement on how best to clinically respond to our situation. In the May issue of the Journal of Clinical Oncology, [...]

Go to Top